Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-label, Phase I Study of NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma

NCT04625205 is registered in ClinicalTrials.gov with BioNTech US Inc. as lead sponsor.

NCT NCT04625205
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04625205 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-label, Phase I Study of NEO-PTC-01 in Patients With Advanced or Metastatic Melanoma
Lead sponsor
BioNTech US Inc.
Phase
Phase 1
Overall status
Terminated
Start date
December 1, 2020
Completion date
March 26, 2025
Enrollment
22 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic melanoma, unresectable melanoma